Sangamo Therapeutics Inc (SGMO)

전일 마감가:

$0.5801

열려 있는:

$0.58

하루 거래량:

2.92M

시가총액:

$126.31M

수익:

$176.23M

순이익/손실:

$-257.83M

주가수익비율:

-0.4198

EPS:

-1.45

순현금흐름:

$-246.00M

1주 성능:

+16.30%

1개월 성능:

+12.31%

6개월 성능:

+73.57%

1년 성능:

-53.18%

1일 변동 폭

$0.57

$0.6182

52주 변동 폭

$0.2911

$1.67

Sangamo Therapeutics Inc Stock (SGMO) Company Profile

명칭

Sangamo Therapeutics Inc

부문

Healthcare (1211)

산업

Biotechnology (697)

전화

510-970-6000

주소

501 Canal Boulevard, Richmond, CA

직원

234

트위터

@sangamotx

다음 수익 날짜

2024-06-04

최신 SEC 제출 서류

SGMO's Discussions on Twitter

Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-04-28	다운그레이드	BofA Securities	Neutral → Underperform
2023-02-27	업그레이드	Wedbush	Neutral → Outperform
2023-01-06	다운그레이드	BofA Securities	Buy → Neutral
2022-06-13	재개	Wedbush	Neutral
2021-05-04	개시	RBC Capital Mkts	Outperform
2021-01-07	재개	Guggenheim	Neutral
2021-01-06	개시	Stifel	Hold
2020-12-16	재개	H.C. Wainwright	Buy
2020-09-08	개시	BofA Securities	Buy
2020-07-07	개시	SunTrust	Buy
2019-08-26	개시	H.C. Wainwright	Buy
2018-11-14	다운그레이드	JP Morgan	Overweight → Neutral
2018-11-09	다운그레이드	Guggenheim	Buy → Neutral
2018-10-10	개시	Guggenheim	Buy
2018-06-20	개시	BofA/Merrill	Buy
2017-11-15	업그레이드	Piper Jaffray	Neutral → Overweight
2017-06-22	재개	Jefferies	Buy
2016-11-01	다운그레이드	Wedbush	Outperform → Neutral
2016-10-19	다운그레이드	Piper Jaffray	Overweight → Neutral
2015-12-04	개시	Wells Fargo	Outperform
2015-10-23	재개	Jefferies	Buy
2013-05-03	개시	BioLogic Equity Research	Sell
2011-02-23	재확인	JMP Securities	Mkt Outperform
2010-07-29	재확인	Wedbush	Outperform
2009-10-19	개시	Brean Murray	Sell
2009-10-07	재확인	Leerink Swann	Outperform
2009-08-25	재확인	JMP Securities	Mkt Outperform

모두보기

Sangamo Therapeutics Inc 주식(SGMO)의 최신 뉴스

HC Wainwright Weighs in on Sangamo Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:SGMO) - MarketBeat

MarketBeat

Sangamo Therapeutics' (SGMO) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

MarketBeat

Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know - Markets Insider

Markets Insider

Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know

Benzinga

This Just In: Analysts Are Boosting Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Outlook for This Year - Simply Wall St

Simply Wall St

Top Ranked Momentum Stocks to Buy for March 5th - Yahoo Movies UK

Yahoo Movies UK

Sangamo Therapeutics Inc (SGMO) 재무 분석

Sangamo Therapeutics Inc (SGMO) 매출 2024

Sangamo Therapeutics Inc (SGMO) 순이익 2024

Sangamo Therapeutics Inc (SGMO) 현금흐름 2024

Sangamo Therapeutics Inc (SGMO) 주당 순이익 2024